U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07408674) titled 'COMPETE-LM Trial: Drug-Coated Balloon-Enhanced Provisional Stenting in Complex Left Main Disease.' on Feb. 06.

Brief Summary: Prospective, physician-initiated, multicenter, randomized, single-blind, controlled trial.

Participants will be randomized (1:1) to a DCB-enhanced strategy (study group) or a conventional strategy (control group).

The study aims to compare the clinical outcomes of conventional provisional stenting (Angiolite in the main branch, with optional side branch stenting if compromised) versus DCB enhanced provisional stenting (Angiolite in the main branch plus Essential Pro in the side branch) in patients with comp...